A large multi-institutional study including about 1,407 TNBC tumours issued after this meta-analysis concluded that the AR-positivity was a marker of good prognosis in USA and Nigerian cohorts, whereas it conferred poor prognosis in Norway, Ireland and Indian cohorts, and was neutral in UK cohort [4]. This evidence concerns the gene AR and neoplasm.